AAAAAA

   
Results: 1-11 |
Results: 11
GENETICALLY-ENGINEERED ALLOGENEIC RENAL-CELL CARCINOMA VACCINES
Authors: SCHENDEL DJ WILLIMSKY G MAGET B CAYEUX S UCKERT W QIN Z OBERNEDER R HOFSTETTER A PEZZUTTO T DORKEN B BLANKENSTEIN T
Citation: Dj. Schendel et al., GENETICALLY-ENGINEERED ALLOGENEIC RENAL-CELL CARCINOMA VACCINES, European journal of cancer, 33, 1997, pp. 35-35
CELLULAR AND MOLECULAR ANALYSES OF MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTED AND NON-MHC-RESTRICTED EFFECTOR-CELLS RECOGNIZING RENAL-CELL CARCINOMAS - PROBLEMS AND PERSPECTIVES FOR IMMUNOTHERAPY
Authors: SCHENDEL DJ OBERNEDER R FALK CS JANTZER P KRESSENSTEIN S MAGET B HOFSTETTER A RIETHMULLER G NOSSNER E
Citation: Dj. Schendel et al., CELLULAR AND MOLECULAR ANALYSES OF MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTED AND NON-MHC-RESTRICTED EFFECTOR-CELLS RECOGNIZING RENAL-CELL CARCINOMAS - PROBLEMS AND PERSPECTIVES FOR IMMUNOTHERAPY, Journal of molecular medicine, 75(6), 1997, pp. 400-413
LIMITATIONS OF REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW
Authors: ZIPPELIUS A KUFER P HONOLD G KOLLERMANN MW OBERNEDER R SCHLIMOK G RIETHMULLER G PANTEL K
Citation: A. Zippelius et al., LIMITATIONS OF REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW, Journal of clinical oncology, 15(7), 1997, pp. 2701-2708
IMMUNOTHERAPY OF METASTATIC RENAL-CELL CA RCINOMA - IS CLINICAL USE JUSTIFIED WITH REGARD TO EFFICACY, SIDE-EFFECTS AND COSTS
Authors: OBERNEDER R KRIEGMAIR M STAEHLER M HOFSTETTER A
Citation: R. Oberneder et al., IMMUNOTHERAPY OF METASTATIC RENAL-CELL CA RCINOMA - IS CLINICAL USE JUSTIFIED WITH REGARD TO EFFICACY, SIDE-EFFECTS AND COSTS, Der Urologe, 36(2), 1997, pp. 130-137
ESTABLISHMENT OF MICROMETASTATIC CARCINOMA CELL-LINES - A NOVEL SOURCE OF TUMOR-CELL VACCINES
Authors: PANTEL K DICKMANNS A ZIPPELIUS A KLEIN C SHI J HOECHTLENVOLLMAR W SCHLIMOK G WECKERMANN D OBERNEDER R FANNING E RIETHMULLER G
Citation: K. Pantel et al., ESTABLISHMENT OF MICROMETASTATIC CARCINOMA CELL-LINES - A NOVEL SOURCE OF TUMOR-CELL VACCINES, Journal of the National Cancer Institute, 87(15), 1995, pp. 1162-1168
INTERFERON-ALPHA AND VINBLASTINE VERSUS MEDROXY-PROGESTERONACETAT IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
Authors: KRIEGMAIR M OBERNEDER R HOFSTETTER A
Citation: M. Kriegmair et al., INTERFERON-ALPHA AND VINBLASTINE VERSUS MEDROXY-PROGESTERONACETAT IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA, European journal of cancer, 31A, 1995, pp. 76-76
VACCINATION FOR TREATMENT OF RENAL-CELL C ANCER
Authors: KRIEGMAIR M OBERNEDER R
Citation: M. Kriegmair et R. Oberneder, VACCINATION FOR TREATMENT OF RENAL-CELL C ANCER, Der Urologe, 34(3), 1995, pp. 204-207
INTERFERON-ALFA AND VINBLASTINE VERSUS MEDROXYPROGESTERONE ACETATE INTHE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
Authors: KRIEGMAIR M OBERNEDER R HOFSTETTER A
Citation: M. Kriegmair et al., INTERFERON-ALFA AND VINBLASTINE VERSUS MEDROXYPROGESTERONE ACETATE INTHE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA, Urology, 45(5), 1995, pp. 758-762
BIOLOGY OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW IN BREAST AND PROSTATE-CANCER
Authors: PANTEL K SCHLIMOK G BRAUN S KUTTER D KLEIN C OBERNEDER R RIESENBERG R RIETHMULLER G
Citation: K. Pantel et al., BIOLOGY OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW IN BREAST AND PROSTATE-CANCER, Journal of cellular biochemistry, 1994, pp. 244-244
IMMUNOCYTOCHEMICAL DETECTION AND PHENOTYPIC CHARACTERIZATION OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PROSTATE-CANCER
Authors: OBERNEDER R RIESENBERG R KRIEGMAIR M BITZER U KLAMMERT R SCHNEEDE P HOFSTETTER A RIETHMULLER G PANTEL K
Citation: R. Oberneder et al., IMMUNOCYTOCHEMICAL DETECTION AND PHENOTYPIC CHARACTERIZATION OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PROSTATE-CANCER, Urological research, 22(1), 1994, pp. 3-8
TUMOR-SPECIFIC LYSIS OF HUMAN RENAL-CELL CARCINOMAS BY TUMOR-INFILTRATING LYMPHOCYTES .1. HLA-A2-RESTRICTED RECOGNITION OF AUTOLOGOUS AND ALLOGENEIC-TUMOR LINES
Authors: SCHENDEL DJ GANSBACHER B OBERNEDER R KRIEGMAIR M HOFSTETTER A RIETHMULLER G SEGURADO OG
Citation: Dj. Schendel et al., TUMOR-SPECIFIC LYSIS OF HUMAN RENAL-CELL CARCINOMAS BY TUMOR-INFILTRATING LYMPHOCYTES .1. HLA-A2-RESTRICTED RECOGNITION OF AUTOLOGOUS AND ALLOGENEIC-TUMOR LINES, The Journal of immunology, 151(8), 1993, pp. 4209-4220
Risultati: 1-11 |